News

The Price Debate

February 02, 2022

As company revenues are gaining a boost from COVID-19, the issue of pricing is being debated once more.

Celebrate the New

February 02, 2022

The process of reshaping inevitably leads to fresh insights.

A License to Innovate

February 02, 2022

Busy is good for business.

Cytiva Provides Arranta Bio with Single-Use Manufacturing Platform for mRNA Products

February 01, 2022

Arranta Bio will use Cytiva’s FlexFactory single-use manufacturing platform to produce mRNA vaccines.

Recipharm Acquires Portuguese CDMO, GenIbet, Boosting Biologics Offering

February 01, 2022

Recipharm will build up its biologics service offering with the acquisition of GenIbet.

Gene Editing Startup Metagenomi Raises $175 Million

January 31, 2022

Metagenomi has successfully raised $175 million for use toward its research pipeline.

Pfizer and Moderna Begin Omicron Vaccine Trials

January 31, 2022

Both Pfizer and Moderna have started clinical trials for their respective Omicron COVID-19 variant vaccine.

Pandemic Preparedness Legislation Bolsters FDA Oversight

January 31, 2022

The draft PREVENT Pandemic Act aims to secure supply chains, expand health data collection, and support access to vital medical products

IonSense’s DART-MS Technology Selected for New Drug Screening Program

January 28, 2022

IonSense’s DART-MS technology offers rapid drug analysis without the need for sample preparation.

Texcell North America Builds New Laboratory Facility

January 28, 2022

Texcell North America’s new lab facility in Frederick, Md., will expand the CRO’s capabilities in R&D cell culture, viral clearance studies, and viral safety testing.